Replies to post #241145 on Biotech Values

[DewDiligence]

BMY 4Q21 results…

PR:
https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2021/BMY-Q42021-Earnings-Press-Release.pdf

CC slides:
https://s21.q4cdn.com/104148044/files/doc_presentations/2021/BMY-2021-Q4-Results-Investor-Presentation.pdf

BMY reiterates 2022 non-GAAP EPS guidance of $7.65-7.95 and the $15B buyback program with $5B of the $15B to be purchased during 1Q22.

[DewDiligence]

BMY executes $5B ASR* agreements, following through on announcement made 1/10/22 (in conjunction with JPM conference):

https://finance.yahoo.com/news/bristol-myers-squibb-enters-5-115900629.html

*Accelerated Share Repurchase.